semaglutide 1.25 mg How to Use Ozempic® Pen Novo Nordisk's 25mg daily pill

Adults with obesity (BMI 30) for weight management

Cardiovascular risk factors in restless legs syndrome

Your skin works hard every day

The Therapeutic Goods Administration's (TGA) warning covers the following glucagon-like peptide-1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and obesity: Semaglutide, sold as Ozempic, Wegovy Tirzepatide, sold as Mounjaro Dulaglutide, sold as Trulicity Liraglutide, sold as Saxenda The TGA said the products had the potential to cause an eye disorder called non-arteritic anterior ischaemic optic neuropathy (NAION)

Remedy Meds compensates with monthly check-ins, live expert sessions, and access to a 10,000+ member community for peer support